vs

Side-by-side financial comparison of EnerSys (ENS) and ResMed (RMD). Click either name above to swap in a different company.

ResMed is the larger business by last-quarter revenue ($1.4B vs $919.1M, roughly 1.5× EnerSys). ResMed runs the higher net margin — 27.6% vs 9.8%, a 17.8% gap on every dollar of revenue. On growth, ResMed posted the faster year-over-year revenue change (11.0% vs 1.4%). Over the past eight quarters, ResMed's revenue compounded faster (7.9% CAGR vs 0.5%).

EnerSys is a stored energy systems and technology provider for industrial applications. The company manufactures reserve-power and motive-power batteries, battery chargers, power equipment, battery accessories and outdoor equipment enclosures.

ResMed Inc. is a medical equipment company based in San Diego, California, and founded in Australia. It primarily provides cloud-connectable medical devices for the treatment of sleep apnea, chronic obstructive pulmonary disease (COPD), and other respiratory conditions. Resmed produced hundreds of thousands of ventilators and bilevel devices to help treat the respiratory symptoms of patients with COVID-19.

ENS vs RMD — Head-to-Head

Bigger by revenue
RMD
RMD
1.5× larger
RMD
$1.4B
$919.1M
ENS
Growing faster (revenue YoY)
RMD
RMD
+9.5% gap
RMD
11.0%
1.4%
ENS
Higher net margin
RMD
RMD
17.8% more per $
RMD
27.6%
9.8%
ENS
Faster 2-yr revenue CAGR
RMD
RMD
Annualised
RMD
7.9%
0.5%
ENS

Income Statement — Q3 FY2026 vs Q4 FY2026

Metric
ENS
ENS
RMD
RMD
Revenue
$919.1M
$1.4B
Net Profit
$90.4M
$392.6M
Gross Margin
30.1%
61.8%
Operating Margin
13.5%
34.6%
Net Margin
9.8%
27.6%
Revenue YoY
1.4%
11.0%
Net Profit YoY
-21.3%
13.9%
EPS (diluted)
$2.40
$2.68

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ENS
ENS
RMD
RMD
Q2 26
$1.4B
Q4 25
$919.1M
$1.4B
Q3 25
$951.3M
$1.3B
Q2 25
$893.0M
$1.3B
Q1 25
$974.8M
$1.3B
Q4 24
$906.2M
$1.3B
Q3 24
$883.7M
$1.2B
Q2 24
$852.9M
$1.2B
Net Profit
ENS
ENS
RMD
RMD
Q2 26
$392.6M
Q4 25
$90.4M
$392.6M
Q3 25
$68.4M
$348.5M
Q2 25
$57.5M
$379.7M
Q1 25
$96.5M
$365.0M
Q4 24
$114.8M
$344.6M
Q3 24
$82.3M
$311.4M
Q2 24
$70.1M
$292.2M
Gross Margin
ENS
ENS
RMD
RMD
Q2 26
61.8%
Q4 25
30.1%
61.8%
Q3 25
29.1%
61.5%
Q2 25
28.4%
60.8%
Q1 25
31.2%
59.3%
Q4 24
32.9%
58.6%
Q3 24
28.5%
58.6%
Q2 24
27.9%
58.5%
Operating Margin
ENS
ENS
RMD
RMD
Q2 26
34.6%
Q4 25
13.5%
34.6%
Q3 25
9.7%
33.4%
Q2 25
9.7%
33.7%
Q1 25
13.5%
33.0%
Q4 24
15.7%
32.5%
Q3 24
11.2%
31.6%
Q2 24
10.7%
31.2%
Net Margin
ENS
ENS
RMD
RMD
Q2 26
27.6%
Q4 25
9.8%
27.6%
Q3 25
7.2%
26.1%
Q2 25
6.4%
28.2%
Q1 25
9.9%
28.3%
Q4 24
12.7%
26.9%
Q3 24
9.3%
25.4%
Q2 24
8.2%
23.9%
EPS (diluted)
ENS
ENS
RMD
RMD
Q2 26
$2.68
Q4 25
$2.40
$2.68
Q3 25
$1.80
$2.37
Q2 25
$1.46
$2.58
Q1 25
$2.39
$2.48
Q4 24
$2.88
$2.34
Q3 24
$2.01
$2.11
Q2 24
$1.71
$1.97

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ENS
ENS
RMD
RMD
Cash + ST InvestmentsLiquidity on hand
$450.1M
$1.4B
Total DebtLower is stronger
$663.8M
Stockholders' EquityBook value
$1.9B
$6.3B
Total Assets
$4.0B
$8.5B
Debt / EquityLower = less leverage
0.11×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ENS
ENS
RMD
RMD
Q2 26
$1.4B
Q4 25
$450.1M
$1.4B
Q3 25
$388.6M
$1.4B
Q2 25
$346.7M
$1.2B
Q1 25
$343.1M
$932.7M
Q4 24
$463.2M
$521.9M
Q3 24
$407.9M
$426.4M
Q2 24
$344.1M
$238.4M
Total Debt
ENS
ENS
RMD
RMD
Q2 26
$663.8M
Q4 25
$403.9M
Q3 25
$408.7M
Q2 25
$658.4M
Q1 25
$1.1B
$663.1M
Q4 24
$662.9M
Q3 24
$667.6M
Q2 24
$697.3M
Stockholders' Equity
ENS
ENS
RMD
RMD
Q2 26
$6.3B
Q4 25
$1.9B
$6.3B
Q3 25
$1.9B
$6.1B
Q2 25
$1.9B
$6.0B
Q1 25
$1.9B
$5.5B
Q4 24
$1.8B
$5.3B
Q3 24
$1.8B
$5.2B
Q2 24
$1.8B
$4.9B
Total Assets
ENS
ENS
RMD
RMD
Q2 26
$8.5B
Q4 25
$4.0B
$8.5B
Q3 25
$4.1B
$8.3B
Q2 25
$4.1B
$8.2B
Q1 25
$4.0B
$7.6B
Q4 24
$4.0B
$7.1B
Q3 24
$4.0B
$7.2B
Q2 24
$3.6B
$6.9B
Debt / Equity
ENS
ENS
RMD
RMD
Q2 26
0.11×
Q4 25
0.06×
Q3 25
0.07×
Q2 25
0.11×
Q1 25
0.57×
0.12×
Q4 24
0.13×
Q3 24
0.13×
Q2 24
0.14×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ENS
ENS
RMD
RMD
Operating Cash FlowLast quarter
$184.6M
Free Cash FlowOCF − Capex
$171.3M
FCF MarginFCF / Revenue
18.6%
Capex IntensityCapex / Revenue
1.4%
Cash ConversionOCF / Net Profit
2.04×
TTM Free Cash FlowTrailing 4 quarters
$441.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ENS
ENS
RMD
RMD
Q2 26
Q4 25
$184.6M
$339.7M
Q3 25
$218.0M
$457.3M
Q2 25
$968.0K
$538.8M
Q1 25
$135.2M
$578.7M
Q4 24
$81.1M
$308.6M
Q3 24
$33.6M
$325.5M
Q2 24
$10.4M
$440.1M
Free Cash Flow
ENS
ENS
RMD
RMD
Q2 26
Q4 25
$171.3M
$311.2M
Q3 25
$197.1M
$414.4M
Q2 25
$-32.1M
$508.2M
Q1 25
$104.9M
$557.9M
Q4 24
$56.8M
$288.0M
Q3 24
$3.3M
$307.7M
Q2 24
$-25.7M
$415.2M
FCF Margin
ENS
ENS
RMD
RMD
Q2 26
Q4 25
18.6%
21.9%
Q3 25
20.7%
31.0%
Q2 25
-3.6%
37.7%
Q1 25
10.8%
43.2%
Q4 24
6.3%
22.5%
Q3 24
0.4%
25.1%
Q2 24
-3.0%
33.9%
Capex Intensity
ENS
ENS
RMD
RMD
Q2 26
Q4 25
1.4%
2.0%
Q3 25
2.2%
3.2%
Q2 25
3.7%
2.3%
Q1 25
3.1%
1.6%
Q4 24
2.7%
1.6%
Q3 24
3.4%
1.5%
Q2 24
4.2%
2.0%
Cash Conversion
ENS
ENS
RMD
RMD
Q2 26
Q4 25
2.04×
0.87×
Q3 25
3.19×
1.31×
Q2 25
0.02×
1.42×
Q1 25
1.40×
1.59×
Q4 24
0.71×
0.90×
Q3 24
0.41×
1.05×
Q2 24
0.15×
1.51×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ENS
ENS

Energy Systems$399.5M43%
Motive Power$352.0M38%
Services$92.6M10%
Transferred Over Time$38.2M4%
Other$36.8M4%

RMD
RMD

Segment breakdown not available.

Related Comparisons